TrialLeukemia & lymphoma2014

A phase 2 study of belinostat (PXD101) in patients with relapsed or refractory acute myeloid leukemia or patients over the age of 60 with newly diagnosed acute myeloid leukemia: a California Cancer Consortium Study.

Mark H Kirschbaum et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.